Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $23.41 in the prior trading day, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $23.39, down -0.09%. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 0.83 million shares were traded. BEAM stock price reached its highest trading level at $23.51 during the session, while it also had its lowest trading level at $22.99.
Ratios:
Our goal is to gain a better understanding of BEAM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 23, 2024, initiated with a Buy rating and assigned the stock a target price of $80.
On January 29, 2024, JP Morgan Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $38 to $40.
BofA Securities Downgraded its Buy to Neutral on December 15, 2023, while the target price for the stock was maintained at $35.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 07 ’24 when Burrell Terry-Ann bought 185,565 shares for $23.00 per share.
Bellon Christine sold 385 shares of BEAM for $9,040 on Oct 01 ’24. The Chief Legal Officer now owns 104,209 shares after completing the transaction at $23.48 per share. On Oct 01 ’24, another insider, Cavanagh Bethany J, who serves as the SVP, Finance and Treasurer of the company, sold 289 shares for $23.48 each. As a result, the insider received 6,785 and left with 44,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 1927700864 and an Enterprise Value of 1006221696. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.47 while its Price-to-Book (P/B) ratio in mrq is 2.26. Its current Enterprise Value per Revenue stands at 2.854 whereas that against EBITDA is -6.178.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $16.95. The 50-Day Moving Average of the stock is -8.60%, while the 200-Day Moving Average is calculated to be -13.77%.
Shares Statistics:
The stock has traded on average 964.10K shares per day over the past 3-months and 762990 shares per day over the last 10 days, according to various share statistics. A total of 81.63M shares are outstanding, with a floating share count of 71.65M. Insiders hold about 13.06% of the company’s shares, while institutions hold 81.25% stake in the company. Shares short for BEAM as of 1726185600 were 10963771 with a Short Ratio of 11.37, compared to 1723680000 on 11178961. Therefore, it implies a Short% of Shares Outstanding of 10963771 and a Short% of Float of 17.419999999999998.
